Your browser doesn't support javascript.
loading
Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial.
Ohmachi, Ken; Tobinai, Kensei; Kinoshita, Tomohiro; Ishikawa, Takayuki; Hatake, Kiyohiko; Ichikawa, Satoshi; Ohmine, Ken; Kamitsuji, Yuri; Choi, Ilseung; Chou, Takaaki; Tsukasaki, Kunihiro; Kumagai, Kyoya; Taniwaki, Masafumi; Uchida, Toshiki; Kikukawa, Yoshitaka; Kubo, Kohmei; Mihara, Keichiro; Tsukamoto, Norifumi; Izutsu, Koji; Yoshida, Isao; Ishida, Fumihiro; Usui, Noriko; Iida, Shinsuke; Murayama, Tohru; Ueda, Eisuke; Kuriki, Hiroshi; Ando, Kiyoshi.
  • Ohmachi K; School of Medicine, Tokai University, 143 Shimokasuya, Isehara, Kanagawa, Japan. 8jmmd004@is.icc.u-tokai.ac.jp.
  • Tobinai K; National Cancer Center Hospital, Tokyo, Japan.
  • Kinoshita T; Aichi Cancer Center, Nagoya, Aichi, Japan.
  • Ishikawa T; Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Hatake K; The Cancer Institute Hospital, Tokyo, Japan.
  • Ichikawa S; Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Ohmine K; Jichi Medical University, Shimotsuke, Tochigi, Japan.
  • Kamitsuji Y; Matsushita Memorial Hospital, Moriguchi, Osaka, Japan.
  • Choi I; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Chou T; Niigata Cancer Center Hospital, Niigata, Japan.
  • Tsukasaki K; National Cancer Center Hospital East, Chiba, Japan.
  • Kumagai K; Chiba Cancer Center, Chiba, Japan.
  • Taniwaki M; Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Uchida T; Japanese Red Cross Nagoya Daini Hospital, Nagoya, Aichi, Japan.
  • Kikukawa Y; Kumamoto University Graduate School of Medicine, Kumamoto, Japan.
  • Kubo K; Aomori Prefectural Central Hospital, Aomori, Japan.
  • Mihara K; Hiroshima University Hospital, Hiroshima, Japan.
  • Tsukamoto N; Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
  • Izutsu K; Toranomon Hospital, Tokyo, Japan.
  • Yoshida I; National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
  • Ishida F; Shinshu University School of Medicine, Nagano, Japan.
  • Usui N; The Jikei University School of Medicine, Tokyo, Japan.
  • Iida S; Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Murayama T; Hyogo Cancer Center, Akashi, Hyogo, Japan.
  • Ueda E; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Kuriki H; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Ando K; School of Medicine, Tokai University, 143 Shimokasuya, Isehara, Kanagawa, Japan.
Int J Hematol ; 108(5): 499-509, 2018 Nov.
Article en En | MEDLINE | ID: mdl-30027429
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Folicular / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Folicular / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2018 Tipo del documento: Article